Serum Institute of India is the vaccine producer that will invest 50 million pounds ($68.24 million) in Oxford Biomedica, one of the COVID-19 vaccine manufacturers...
The Drug Controller General of India (DCGI) has approved the restricted emergency use of the Sputnik V vaccine late Monday night. With this, India now...
India has been at the forefront in fighting the coronavirus pandemic and โreally stands outโ in terms of its vaccine policy, Chief Economist of the...
Rising Sun Holdings, a company controlled in a personal capacity by Serum Institute of India CEO Adar Poonawalla, announced a transaction on February 10 to acquire a...